文献速递慢性静脉疾病

髂静脉Wallstent支架的靶向过度扩张再干预

Caliber-targeted reinterventional overdilation of iliac vein Wallstents.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-01-01

该单中心回顾性研究纳入274例因支架内再狭窄或支架压缩而接受再干预球囊扩张的髂静脉Wallstent肢体,其中71例等径扩张有效,203例等径扩张无效后行超过额定直径2-4 mm(10%-20%)的过度扩张。结果显示过度扩张组在术中血流通道面积改善、临床结局及外周静脉压改善方面均显著优于等径扩张组,且扩张效果在术后20个月内经双功超声监测保持耐久。

要点

  • Wallstent支架再干预时,等径扩张无效者可考虑超过额定直径2-4 mm的过度扩张。
  • 过度扩张可显著改善术中血流通道面积、临床结局及外周静脉压。
  • 过度扩张的管径改善在术后20个月内经双功超声监测显示耐久。

核心结论

  • 对于髂静脉Wallstent支架内再狭窄或支架压缩,过度扩张是纠正病变并恢复目标管径的有效技术。
  • 与等径扩张相比,过度扩张获得更持久的管径改善、更优的临床结局及外周静脉高压的降低。

研究设计与样本

  • 单中心回顾性分析,数据来自带时间戳的电子病历系统。
  • 共274例既往置入支架的肢体因支架内再狭窄或支架压缩接受再干预球囊扩张。
  • 71例等径扩张至支架额定直径有效(等径扩张亚组),203例等径扩张无效后行超过额定直径2-4 mm(10%-20%)的过度扩张(过度扩张亚组)。
  • 术中采用血管内超声平面测量法计算支架压缩、支架内再狭窄及其清除情况。
  • 术后通过临床和双功超声检查随访,中位随访18个月(范围1-35个月)。

主要发现

  • 过度扩张组在术中血管内超声评估的血流通道面积改善显著优于等径扩张组。
  • 过度扩张组临床结局显著更好,外周静脉压改善显著更优。
  • 双功超声监测显示过度扩张的管径改善在干预后长达20个月内保持耐久。

临床怎么用

  • 在髂静脉Wallstent支架再干预中,若等径扩张至额定直径无效,可考虑超过额定直径2-4 mm(10%-20%)的过度扩张。
  • 术中可借助血管内超声评估支架压缩和支架内再狭窄的清除效果及目标管径的达成。
  • 术后应通过临床和双功超声随访监测管径耐久性及临床结局。

局限性

  • 本研究为单中心回顾性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wallstents (Boston Scientific, Marlborough, Mass) are most commonly used in iliac-caval stenting. Approximately 20% of stented limbs require reintervention to correct in-stent restenosis (ISR) or stent compression (SC). Corrective balloon dilation to rated stent caliber (isodilation) is not always successful. We investigated whether modest overdilation of the Wallstent by 2 to 4 mm (10%-20%) beyond the rated diameter would yield better mechanical clearance of ISR/SC, leading to a larger flow channel, improved conductance, reduction of peripheral venous pressure, and better clinical outcome. Outflow lumen caliber exponentially influences peripheral venous pressure, a key mechanism in chronic venous disease. Beyond the mechanical effects, the rationale for overdilation rests on the theory that an improvement in flow channel at the margins may yield an outsized pressure reduction and clinical improvement. METHODS: There were 274 previously stented limbs that underwent reinterventional balloon dilation for clearance of ISR/SC during a recent 3-year period. Isodilation to rated diameter of the stent was judged effective in 71 limbs (isodilated subset); 203 limbs (overdilated subset) for which initial isodilation was ineffective underwent overdilation of the resident Wallstent by 2 to 4 mm (10%-20%) beyond the original rated diameter. IVUS planimetry was used intraoperatively to calculate SC and ISR and their subsequent clearance in the two subsets. The dilated segments were observed by clinical and duplex ultrasound examination afterward. The two subsets were compared in the following outcome measures: intraprocedural efficacy in clearing ISR/SC and achieving target lumen caliber, subsequent clinical outcomes, duplex ultrasound caliber durability, and improvement in supine foot venous pressures. This is a single-center retrospective analysis of data contemporaneously entered into a time stamped electronic medical record system. RESULTS: The median follow-up was 18 months (range, 1-35 months). Overdilation of the stent resulted in significantly better intraoperative flow channel area improvement per intravascular ultrasound. This was reflected in significantly better clinical outcome and improvement in peripheral venous pressure in the overdilated subset. Overdilation appeared to be durable up to 20 months after intervention by duplex ultrasound monitoring. CONCLUSIONS: Overdilation appears to be a useful technique to correct ISR/SC and to restore target lumen caliber during reinterventional correction of a resident iliac vein Wallstent. More durable caliber improvement, superior clinical outcome, and reduction in peripheral venous hypertension were noticed in overdilated stents compared with isodilation.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Raju S, Knight A, Buck W, et al. Caliber-targeted reinterventional overdilation of iliac vein Wallstents. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30771830. doi:10.1016/j.jvsv.2018.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。